Amgen’s Repatha Cholesterol Drug Cuts Risk of Cardiovascular Events in Clinical Trial

Поделиться
HTML-код
  • Опубликовано: 29 авг 2024
  • On www.xtalks.com - Initial results from Amgen’s FOURIER clinical trial show that Repatha reduces the risk of cardiovascular events in patients with heart disease.
    To read more: xtalks.com/Repa...
    For more news stories, visit: xtalks.com/News...
    Receive weekly news updates right in your inbox: xtalks.com/subs...
    Listen live and interact with featured speakers on our upcoming Life Science webinars: xtalks.com/upco...

Комментарии • 1

  • @arturo99jr
    @arturo99jr Год назад +1

    Thank you for the information